
elvitegravir-cobicistat-emtricitabin-tenofovir disoprox oral brand names and other generic formulations include:
naproxen-esomeprazole magnesium oral brand names and other generic formulations include:
elvitegravir-cobicistat-emtricitabin-tenofovir disoprox oral and naproxen-esomeprazole magnesium oral
elvitegravir-cobicistat-emtricitabin-tenofovir disoprox oral , naproxen-esomeprazole magnesium oral . Either increases toxicity of the other by reducing drug clearance through the kidneys. Combination may increase side effects; alternatives to NSAIDs should be considered.
elvitegravir-cobicistat-emtricitabin-tenofovir disoprox oral and naproxen-esomeprazole magnesium oral
elvitegravir-cobicistat-emtricitabin-tenofovir disoprox oral , naproxen-esomeprazole magnesium oral . Either increases toxicity of the other by decreasing renal clearance. Toxicity may result from coadministration of emtricitabine and tenofovir with other drugs that are also primarily excreted by glomerular filtration and/or active tubular secretion including high-dose or multiple-dose NSAIDs; alternatives to NSAIDs should be considered
Check for more interactions with the Drug Interaction Checker
Drug Interaction Categories
Contraindicated
Never use this combination of drugs because of high risk for dangerous interaction
Serious
Potential for serious interaction; regular monitoring by your doctor required or alternate medication may be needed
Significant
Potential for significant interaction (monitoring by your doctor is likely required)
Minor
Interaction is unlikely, minor, or nonsignificant